Skip to main content
SpringerLink
Log in

Advances in Endometrial Cancer Diagnosis

  • Chapter
  • First Online:
Management of Endometrial Cancer

  • 698 Accesses

Abstract

Endometrial cancer is staged according to the International Federation of Gynecology and Obstetrics (FIGO) guidelines which are developed independently from imaging [1]. Major prognostic factors for endometrial cancer comprise histologic grade and lymphovascular invasion, local tumor extent including depth of myometrial invasion and cervical stromal involvement, and extrauterine tumor spread including nodal and distant metastatic spread [2]. Although FIGO guidelines do not recommend cross-sectional imaging as routine diagnostic modalities, CT, MRI, and FDG-PET/CT have an increasing role in the management of endometrial cancer patients as they also allow assessment of distant nodal or visceral disease spread [3]. At the time of diagnosis of endometrial cancer, imaging is most important for staging of locoregional and distant tumor extent and for prognostication. The purpose of this chapter is to present a general overview of conventional and newly developed imaging concepts for endometrial cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet. 2009;105(2):109.

    Article  PubMed  Google Scholar 

  2. Larson DM, Connor GP, Broste SK, Krawisz BR, Johnson KK. Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol. 1996;88(3):394–8.

    Article  CAS  PubMed  Google Scholar 

  3. Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, Sessa C, ESMO Guidelines Working Group. Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi33–8.

    Article  PubMed  Google Scholar 

  4. Berman ML, Ballon SC, Lagasse LD, Watring WG. Prognosis and treatment of endometrial cancer. Am J Obstet Gynecol. 1980;136(5):679–88.

    Article  CAS  PubMed  Google Scholar 

  5. Patel S, Liyanage SH, Sahdev A, Rockall AG, Reznek RH. Imaging of endometrial and cervical cancer. Insights Imaging. 2010;1(5–6):309–28.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Connor JP, Andrews JI, Anderson B, Buller RE. Computed tomography in endometrial carcinoma. Obstet Gynecol. 2000;95(5):692–6.

    CAS  PubMed  Google Scholar 

  7. Tsili AC, Tsampoulas C, Dalkalitsis N, Stefanou D, Paraskevaidis E, Efremidis SC. Local staging of endometrial carcinoma: role of multidetector CT. Eur Radiol. 2008;18(5):1043–8.

    Article  CAS  PubMed  Google Scholar 

  8. Kinkel K, Forstner R, Danza FM, Oleaga L, Cunha TM, Bergman A, Barentsz JO, Balleyguier C, Brkljacic B, Spencer JA. Staging of endometrial cancer with MRI: guidelines of the European Society of Urogenital Imaging. Eur Radiol. 2009;19(7):1565–74.

    Article  CAS  PubMed  Google Scholar 

  9. Beddy P, O’Neill AC, Yamamoto AK, Addley HC, Reinhold C, Sala E. FIGO staging system for endometrial cancer: added benefits of MR imaging. Radiographics. 2012;32(1):241–54. https://doi.org/10.1148/rg.321115045.

    Article  PubMed  Google Scholar 

  10. Beddy P, Moyle P, Kataoka M, Yamamoto AK, Joubert I, Lomas D, Crawford R, Sala E. Evaluation of depth of myometrial invasion and overall staging in endometrial cancer: comparison of diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology. 2012;262(2):530–7.

    Article  PubMed  Google Scholar 

  11. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol. 2007;188:1622–35.

    Article  PubMed  Google Scholar 

  12. Spencer JA, Messiou C, Swift SE. MR staging of endometrial cancer: needed or wanted? Cancer Imaging. 2008;8:1–5.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kinkel K, Kaji Y, Yu KK, Segal MR, Lu Y, Powell CB, Hricak H. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology. 1999;212(3):711–8.

    Article  CAS  PubMed  Google Scholar 

  14. Luomaranta A, Leminen A, Loukovaara M. Magnetic resonance imaging in the assessment of high-risk features of endometrial carcinoma: a meta-analysis. Int J Gynecol Cancer. 2015;25(5):837–42.

    Article  PubMed  Google Scholar 

  15. Lin G, Ng KK, Chang CJ, Wang JJ, Ho KC, Yen TC, Wu TI, Wang CC, Chen YR, Huang YT, Ng SH, Jung SM, Chang TC, Lai CH. Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging—initial experience. Radiology. 2009;250(3):784–92.

    Article  PubMed  Google Scholar 

  16. Shen SH, Chiou YY, Wang JH, Yen MS, Lee RC, Lai CR, Chang CY. Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancer. AJR Am J Roentgenol. 2008;190(2):481–8.

    Article  PubMed  Google Scholar 

  17. Rechichi G, Galimberti S, Signorelli M, Perego P, Valsecchi MG, Sironi S. Myometrial invasion in endometrial cancer: diagnostic performance of diffusion-weighted MR imaging at 1.5-T. Eur Radiol. 2010;20(3):754–62.

    Article  PubMed  Google Scholar 

  18. Fujii S, Matsusue E, Kigawa J, Sato S, Kanasaki Y, Nakanishi J, Sugihara S, Kaminou T, Terakawa N, Ogawa T. Diagnostic accuracy of the apparent diffusion coefficient in differentiating benign from malignant uterine endometrial cavity lesions: initial results. Eur Radiol. 2008;18(2):384–9.

    Article  PubMed  Google Scholar 

  19. Tamai K, Koyama T, Saga T, Umeoka S, Mikami Y, Fujii S, Togashi K. Diffusion-weighted MR imaging of uterine endometrial cancer. J Magn Reson Imaging. 2007;26(3):682–7.

    Article  PubMed  Google Scholar 

  20. Rechichi G, Galimberti S, Signorelli M, Franzesi CT, Perego P, Valsecchi MG, Sironi S. Endometrial cancer: correlation of apparent diffusion coefficient with tumor grade, depth of myometrial invasion, and presence of lymph node metastases. AJR Am J Roentgenol. 2011;197(1):256–62.

    Article  PubMed  Google Scholar 

  21. Bharwani N, Miquel ME, Sahdev A, Narayanan P, Malietzis G, Reznek RH, Rockall AG. Diffusion-weighted imaging in the assessment of tumour grade in endometrial cancer. Br J Radiol. 2011;84(1007):997–1004.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Nougaret S, Reinhold C, Alsharif SS, Addley H, Arceneau J, Molinari N, Guiu B, Sala E. Endometrial cancer: combined MR volumetry and diffusion-weighted imaging for assessment of myometrial and lymphovascular invasion and tumor grade. Radiology. 2015;276(3):797–808.

    Article  PubMed  Google Scholar 

  23. Antonsen SL, Jensen LN, Loft A, Berthelsen AK, Costa J, Tabor A, Qvist I, Hansen MR, Fisker R, Andersen ES, Sperling L, Nielsen AL, Asmussen J, Høgdall E, Fagö-Olsen CL, Christensen IJ, Nedergaard L, Jochumsen K, Høgdall C. MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer—a multicenter prospective comparative study. Gynecol Oncol. 2013;128(2):300–8.

    Article  CAS  PubMed  Google Scholar 

  24. Nakamura K, Joja I, Fukushima C, Haruma T, Hayashi C, Kusumoto T, Seki N, Hongo A, Hiramatsu Y. The preoperative SUVmax is superior to ADCmin of the primary tumour as a predictor of disease recurrence and survival in patients with endometrial cancer. Eur J Nucl Med Mol Imaging. 2013;40(1):52–60.

    Article  CAS  PubMed  Google Scholar 

  25. Kitajima K, Kita M, Suzuki K, Senda M, Nakamoto Y, Sugimura K. Prognostic significance of SUVmax (maximum standardized uptake value) measured by [18F]FDG PET/CT in endometrial cancer. Eur J Nucl Med Mol Imaging. 2012;39(5):840–5.

    Article  PubMed  Google Scholar 

  26. Husby JA, Reitan BC, Biermann M, Trovik J, Bjørge L, Magnussen IJ, Salvesen ØO, Salvesen HB, Haldorsen IS. Metabolic tumor volume on 18F-FDG PET/CT improves preoperative identification of high-risk endometrial carcinoma patients. J Nucl Med. 2015;56(8):1191–8.

    Article  CAS  PubMed  Google Scholar 

  27. Nakamura K, Hongo A, Kodama J, Hiramatsu Y. The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer. Gynecol Oncol. 2011;123(1):82–7.

    Article  PubMed  Google Scholar 

  28. Lee JH, Dubinsky T, Andreotti RF, Cardenes HR, Dejesus Allison SO, Gaffney DK, Glanc P, Horowitz NS, Jhingran A, Lee SI, Puthawala AA, Royal HD, Scoutt LM, Small W Jr, Varia MA, Zelop CM, Expert Panel on Women’s Imaging and Radiation Oncology-Gynecology. ACR appropriateness criteria pretreatment evaluation and follow-up of endometrial cancer of the uterus. Ultrasound Q. 2011;27(2):139–45.

    Article  PubMed  Google Scholar 

  29. Roy C, Bierry G, Matau A, Bazille G, Pasquali R. Value of diffusion-weighted imaging to detect small malignant pelvic lymph nodes at 3 T. Eur Radiol. 2010;20(8):1803–11.

    Article  PubMed  Google Scholar 

  30. Lin G, Ho KC, Wang JJ, Ng KK, Wai YY, Chen YT, Chang CJ, Ng SH, Lai CH, Yen TC. Detection of lymph node metastasis in cervical and uterine cancers by diffusion-weighted magnetic resonance imaging at 3T. J Magn Reson Imaging. 2008;28(1):128–35.

    Article  PubMed  Google Scholar 

  31. Rechichi G, Galimberti S, Oriani M, Perego P, Valsecchi MG, Sironi S. ADC maps in the prediction of pelvic lymph nodal metastatic regions in endometrial cancer. Eur Radiol. 2013;23(1):65–74.

    Article  PubMed  Google Scholar 

  32. Kitajima K, Murakami K, Kaji Y, Sugimura K. Spectrum of FDG PET/CT findings of uterine tumors. AJR Am J Roentgenol. 2010;195(3):737–43.

    Article  PubMed  Google Scholar 

  33. Choi HJ, Ju W, Myung SK, Kim Y. Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: meta-analysis. Cancer Sci. 2010;101(6):1471–9.

    Article  CAS  PubMed  Google Scholar 

  34. Chang MC, Chen JH, Liang JA, Yang KT, Cheng KY, Kao CH. 18F-FDG PET or PET/CT for detection of metastatic lymph nodes in patients with endometrial cancer: a systematic review and meta-analysis. Eur J Radiol. 2012;81(11):3511–7.

    Article  PubMed  Google Scholar 

  35. Kitajima K, Murakami K, Yamasaki E, Fukasawa I, Inaba N, Kaji Y, Sugimura K. Accuracy of 18F-FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer. AJR Am J Roentgenol. 2008;190:1652–8.

    Article  PubMed  Google Scholar 

  36. Signorelli M, Crivellaro C, Buda A, Guerra L, Fruscio R, Elisei F, Dolci C, Cuzzocrea M, Milani R, Messa C. Staging of high-risk endometrial cancer with pet/ct and sentinel lymph node mapping. Clin Nucl Med. 2015;40(10):780–5.

    Article  PubMed  Google Scholar 

  37. Picchio M, Mangili G, Samanes Gajate AM, De Marzi P, Spinapolice EG, Mapelli P, Giovacchini G, Sigismondi C, Viganò R, Sironi S, Messa C. High-grade endometrial cancer: value of [(18)F]FDG PET/CT in preoperative staging. Nucl Med Commun. 2010;31(6):506–12.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Radiology, Universitair Ziekenhuis Leuven, Leuven, Belgium

    Vincent Vandecaveye

Authors
  1. Vincent Vandecaveye
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vincent Vandecaveye .

Editor information

Editors and Affiliations

  1. Rigshospitalet, Copenhagen University Rigshospitalet, København Ø, Denmark

    Mansoor R. Mirza

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Vandecaveye, V. (2020). Advances in Endometrial Cancer Diagnosis. In: Mirza, M. (eds) Management of Endometrial Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-64513-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-64513-1_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-64512-4

  • Online ISBN: 978-3-319-64513-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation